DRKS00018102
尚未招募
不适用
Molecular diagnostics of brain tumors using third-generation sequencing - nanoDx
Charité Campus Charité Mitte0 个研究点目标入组 211 人2021年5月21日
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- brain tumor
- 发起方
- Charité Campus Charité Mitte
- 入组人数
- 211
- 状态
- 尚未招募
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Female or male individuals with planned biopsy or resection of a suspected brain tumor as part of routine clinical procedures, who have given written informed consent.
排除标准
- 未提供
结局指标
主要结局
未指定
相似试验
进行中（未招募）
不适用
iquid biopsy of brain tumors using cerebrospinal fluid analysisHealth Condition 1: C719- Malignant neoplasm of brain, unspecifiedCTRI/2022/06/042986Strand Life Sciences Pvt Ltd
尚未招募
不适用
*Non-invasive phenotyping of molecular brain tumour profiles using novel advanced MR imaging and analysis'NL-OMON47240Erasmus MC, Universitair Medisch Centrum Rotterdam300
进行中（未招募）
1 期
Tumor profilingPatients with locally advanced and/ or metastasized carcinoma for whom no further evidence-based drug treatment is established.A progression of the tumor is confirmed due to the last evidence-based drug therapy. Due to circulating tumor-DNA (ctDNA) in a blood sample and/or tissue sample of metastasis, a molecular-biologic tumor profiling is performed and an adapted tumor-specific drug therapy is selected.Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2014-005341-44-ATMedical University of Graz64
进行中（未招募）
4 期
Are RNA signatures (biomarkers) in the tissue which surrounds the joints (synovial tissue) from patients with rheumatoid arthritis predictive of response to drug treatments?Rheumatoid arthritisMusculoskeletal DiseasesISRCTN44988547Queen Mary University of London240
招募中
1 期
The 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) studyRheumatoid ArthritisMedDRA version: 21.0Level: PTClassification code: 10039073Term: Rheumatoid arthritis Class: 100000004859Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]CTIS2022-502021-18-00Queen Mary University Of London240